Anti-AKT1 (phospho S129) antibody [EPR6150]
- RabMAb
- Recombinant
- Lab Essentials
- 20ul selling size
- What is this?
4
(4 Reviews)
|
(56 Publications)
Rabbit Recombinant Monoclonal AKT1 phospho S129 antibody. Suitable for WB and reacts with Human, Mouse, Rat samples. Cited in 56 publications.
View Alternative Names
PKB, RAC, AKT1, RAC-alpha serine/threonine-protein kinase, Protein kinase B, Protein kinase B alpha, Proto-oncogene c-Akt, RAC-PK-alpha, PKB alpha
- WB
Unknown
Western blot - Anti-AKT1 (phospho S129) antibody [EPR6150] (AB133458)
All lanes:
Western blot - Anti-AKT1 (phospho S129) antibody [EPR6150] (ab133458) at 1/1000 dilution
Lane 1:
MCF-7 cell lysate at 10 µg
Lane 2:
MCF-7 cell lysate treated with Alkaline Phosphatase at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit IgG at 1/2000 dilution
Predicted band size: 55 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-AKT1 (phospho S129) antibody [EPR6150] (AB133458)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
- WB
CiteAb
Western blot - Anti-AKT1 (phospho S129) antibody [EPR6150] (AB133458)
AKT1 (phospho S129) western blot using anti-AKT1 (phospho S129) antibody [EPR6150] ab133458. Publication image and figure legend from Sun, L., Jin, X., et al., 2019, BMC Cancer, PubMed 30890138.
ab133458 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab133458 please see the product overview.
Swainsonine impeded the activation of PI3K/AKT/mTOR pathway by repressing miR-92a expression. After transfection and treatment, a and b p/t-phosphatidylinositol-3 kinase (PI3K) and p/t-protein kinase B (AKT) were appraised by exploiting western blot assay; c and d p/t-mammalian target of rapamycin (mTOR) and p/t-phosphorylated and total 70-kDa ribosomal protein S6 kinase (p70S6K) were appraised by utilizing western blot. *p < 0.05; ***p < 0.001
false
Related conjugates and formulations (1)
-
Anti-AKT1 (phospho S129) antibody [EPR6150] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
AKT1 regulates a broad spectrum of cellular functions through signaling pathways. It is an important player in the phosphatidylinositol 3-kinase (PI3K) and AKT pathway forming part of a complex involved in promoting cell survival and growth. AKT1 interacts closely with other proteins such as mTOR influencing cellular metabolism and autophagy. The phosphorylation state of AKT1 is critical for its activity with modifications like p-AKT S473 impacting its interaction with cellular substrates.
Pathways
AKT1 participates in the PI3K/AKT/mTOR signaling cascade instrumental in cell proliferation and metabolism. AKT1 integrates signals from insulin and growth factors modulating pathways that control cell growth and glucose uptake. This pathway involves proteins like mTOR and phospho-AKT which coordinate cellular responses to external stimuli. AKT1’s phosphorylation at serine 473 and the involvement of AKT1 E17K a gain-of-function mutation influence these pathways significantly.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (56)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 15:20922 PubMed40594996
2025
Applications
Unspecified application
Species
Unspecified reactive species
Islets 17:2515332 PubMed40474387
2025
Applications
Unspecified application
Species
Unspecified reactive species
Open biology 14:240205 PubMed39657822
2024
Applications
Unspecified application
Species
Unspecified reactive species
iScience 27:111212 PubMed39559755
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 15:1378305 PubMed38779664
2024
Applications
Unspecified application
Species
Unspecified reactive species
Haematologica 108:797-810 PubMed36226498
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 41:111891 PubMed36577384
2022
Applications
Unspecified application
Species
Unspecified reactive species
Nutrients 14: PubMed35893859
2022
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 23:414 PubMed35601067
2022
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicines 10: PubMed35625703
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com